Cargando…

A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder

Background: Suboptimal treatment response during anti-depressive treatment is fairly common with the first antidepressant (AD) choice, followed by switching to another agent in the majority of cases. However, the efficacy of this strategy over continuation of the original agent is less solidly docum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szekeres, Gyorgy, Rozsa, Sandor, Dome, Peter, Barsony, Gabor, Gonda, Xenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248014/ https://www.ncbi.nlm.nih.gov/pubmed/34220591 http://dx.doi.org/10.3389/fpsyt.2021.689143

Ejemplares similares

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Affective Temperaments, Panic Disorder and Their Bipolar Connections
por: Belteczki, Zsuzsanna, et al.
Publicado: (2021)

Recent Stressful Life Events in Euthymic Major Depressive Disorder Patients: Sociodemographic and Clinical Characteristics
por: Serafini, Gianluca, et al.
Publicado: (2020)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP)
por: de Heer, Eric W., et al.
Publicado: (2018)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
por: Elemery, Monika, et al.
Publicado: (2022)

Suicide Risk in Bipolar Disorder: A Brief Review
por: Dome, Peter, et al.
Publicado: (2019)

Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
por: Gay, Florian, et al.
Publicado: (2022)

Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
por: Ge, Fenfen, et al.
Publicado: (2021)

The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: a cross-sectional multicentered study
por: Alswat, Anas M., et al.
Publicado: (2023)

Theta oscillations: A rhythm difference comparison between major depressive disorder and anxiety disorder
por: Zhang, Yu, et al.
Publicado: (2022)

Duloxetine for the treatment of generalized anxiety disorder: a review
por: Khan, Ahsan Y, et al.
Publicado: (2009)

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan
por: Afridi, Muhammad Iqbal, et al.
Publicado: (2020)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
por: Mattingly, Gregory W., et al.
Publicado: (2022)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

Commentary: A Neural Basis for the Acquired Capacity for Suicide
por: Gonda, Xenia
Publicado: (2017)

Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder
por: Lazary, Judit, et al.
Publicado: (2021)

Cognitive Control Functions in Unipolar Major Depression with and without Co-Morbid Anxiety Disorder
por: Lyche, Pia, et al.
Publicado: (2010)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
por: Kang, Seung-Gul, et al.
Publicado: (2011)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
por: Norman, Trevor R, et al.
Publicado: (2010)

Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
por: De Berardis, Domenico, et al.
Publicado: (2017)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
por: Moon, Seok Woo, et al.
Publicado: (2023)

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
por: Mattingly, Gregory, et al.
Publicado: (2023)

Nature and Nurture: Effects of Affective Temperaments on Depressive Symptoms Are Markedly Modified by Stress Exposure
por: Gonda, Xenia, et al.
Publicado: (2020)

Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2010)

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

“Out, out, brief candle! Life’s but a walking shadow”: 5-HTTLPR Is Associated With Current Suicidal Ideation but Not With Previous Suicide Attempts and Interacts With Recent Relationship Problems
por: Bokor, Janos, et al.
Publicado: (2020)

Association of Subclinical Hypothyroidism With Anxiety Symptom in Young First-Episode and Drug-Naïve Patients With Major Depressive Disorder
por: Yang, Ruchang, et al.
Publicado: (2022)

Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis
por: Wu, Tao, et al.
Publicado: (2023)

Efficacy of Artificial Intelligence-Assisted Psychotherapy in Patients With Anxiety Disorders: A Prospective, National Multicenter Randomized Controlled Trial Protocol
por: Su, Shanshan, et al.
Publicado: (2022)

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
por: Garakani, Amir, et al.
Publicado: (2021)

Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders
por: Lai, Chien-Han, et al.
Publicado: (2021)

Duloxetine 60 mg once daily in the treatment of milder major depressive disorder
por: Perahia, DGS, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_7ol2rbnlfrsrsum3e98sksd1r7